Skip to content
healthcare.dev

FULVESTRANT

NDC 70700-284, fulvestrant, injection, solution, from Xiromed, LLC.

Product NDC
70700-284
Status
Listed
Labeler
Xiromed, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213553
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70700-284 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
70700-284-98707000284982 SYRINGE, GLASS in 1 CARTON (70700-284-98) / 5 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/840cd7c0-9f33-f74e-f136-de7fe899bfb4
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70700-284

Use it

Look up 70700-284 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70700-284 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70700-284. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.